<?xml version="1.0" encoding="UTF-8" ?>
<?xml-stylesheet type="text/xsl" href="http://articles.mercola.com/utility/FeedStylesheets/rss.xsl" media="screen"?><rss version="2.0" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:slash="http://purl.org/rss/1.0/modules/slash/" xmlns:wfw="http://wellformedweb.org/CommentAPI/"><channel><title>Safe Minds Assessment of the Thimerosal-Containing Vaccine Study</title><link>http://articles.mercola.com/sites/articles/archive/2002/12/30/thimerosal-vaccines.aspx</link><description>Contact: Sallie Bernard, executive director, Safe Minds E-mail: sbernard@arcresearch.com ; Phone: 908 295-6648; Web: http://www.safeminds.org Introduction This analysis describes the concerns that Safe Minds has over a recently published study in The</description><dc:language>en</dc:language><generator>CommunityServer 2008.5 SP1 (Build: 31106.3070)</generator></channel></rss>